Old Web
English
Sign In
Acemap
>
authorDetail
>
Koby Mok
Koby Mok
Georgetown University Medical Center
multicenter study
Monoclonal antibody
Medicine
RNA
Angiotensin II receptor type 1
3
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis:
2020
Multiple Sclerosis Journal
Edward Fox
Amy E. Lovett-Racke
Matthew Gormley
Yue Liu
Maria Petracca
Sirio Cocozza
Richard A. Shubin
Sibyl Wray
Michael S. Weiss
Jenna A Bosco
Sean A Power
Koby Mok
Matilde Inglese
Show All
Source
Cite
Save
Citations (23)
Final Results of a Phase 2 Multicenter Study of Ublituximab, a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Patients with RMS
2019
Edward J. Fox
Amy E. Lovett-Racke
Matthew Gormley
Yue Liu
Maria Petracca
Matilde Inglese
S. Cocozza
Sibyl Wray
Richard Shubin
Jenna A Bosco
Sean A Power
Michael D. Weiss
Koby Mok
James L Eubanks
Show All
Source
Cite
Save
Citations (0)
Analysis of Cytosolic Proteins that Bind to the 5′ Leader Sequence of the Angiotensin AT1 Receptor by RNA Electromobility Shift Assay
2001
Methods in molecular medicine
Zheng Wu
Kamakshi Krishnamurthi
Koby Mok
Kathryn Sandberg
Show All
Source
Cite
Save
Citations (0)
1